Reuters logo
BRIEF-Hangzhou firm to acquire stake in Zhenxing Biopharmaceutical & Chemical
June 27, 2017 / 1:42 PM / 3 months ago

BRIEF-Hangzhou firm to acquire stake in Zhenxing Biopharmaceutical & Chemical

June 27 (Reuters) - Zhenxing Biopharmaceutical & Chemical Co Ltd

* Says Hangzhou investment firm plans to acquire 27.5 percent stake in the company at 36 yuan per share for 2.7 billion yuan ($396.46 million)

* Says Hangzhou investment firm will become its owner after transaction

Source text in Chinese: bit.ly/2tizCso

Further company coverage: ($1 = 6.8102 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below